NYSE:CLBCore Laboratories Stock Price, Forecast & News

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CLB shares have increased by 98.2% and is now trading at $21.66. View which stocks have been most impacted by Coronavirus.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 10 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Core Laboratories.

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Core Laboratories.

Core Laboratories will be holding an earnings conference call on Wednesday, July 22nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Core Laboratories (NYSE:CLB) announced its quarterly earnings data on Wednesday, April, 22nd. The oil and gas company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.33 by $0.02. The oil and gas company earned $152.40 million during the quarter, compared to the consensus estimate of $151.37 million. Core Laboratories had a positive return on equity of 46.28% and a negative net margin of 7.21%. Core Laboratories's quarterly revenue was down 9.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.44 EPS. View Core Laboratories' earnings history.

Core Laboratories announced a quarterly dividend on Tuesday, April 28th. Investors of record on Friday, May 8th will be paid a dividend of $0.01 per share on Tuesday, May 19th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.18%. The ex-dividend date is Thursday, May 7th. View Core Laboratories' dividend history.

14 equities research analysts have issued 1-year target prices for Core Laboratories' stock. Their forecasts range from $7.50 to $48.00. On average, they anticipate Core Laboratories' stock price to reach $24.81 in the next year. This suggests a possible upside of 14.5% from the stock's current price. View analysts' price targets for Core Laboratories.

Media headlines about CLB stock have been trending negative on Thursday, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Core Laboratories earned a coverage optimism score of -2.1 on InfoTrie's scale. They also gave media stories about the oil and gas company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Core Laboratories.

Core Laboratories saw a increase in short interest in June. As of June 30th, there was short interest totaling 8,250,000 shares, an increase of 14.1% from the June 15th total of 7,230,000 shares. Based on an average trading volume of 1,580,000 shares, the short-interest ratio is presently 5.2 days. Approximately 18.8% of the shares of the company are short sold. View Core Laboratories' Current Options Chain.

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), RPC (RES), Liberty Oilfield Services (LBRT), National Energy Services Reunited (NESR), Oceaneering International (OII), Propetro (PUMP), Helix Energy Solutions Group (HLX), NexTier Oilfield Solutions (NEX), Franks International (FI), Select Energy Services (WTTR), Keane Group (FRAC), Key Energy Services (KEGX), North American Construction Group (NOA), Hurricane Energy (HRCXF) and Natural Gas Services Group (NGS). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Starbucks (SBUX), Micron Technology (MU), Gilead Sciences (GILD), Netflix (NFLX), AT&T (T) and Baidu (BIDU).

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories' stock is owned by a variety of retail and institutional investors. Top institutional investors include Envestnet Asset Management Inc. (0.07%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig. View institutional ownership trends for Core Laboratories.

CLB stock was acquired by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc.. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno. View insider buying and selling activity for Core Laboratories.

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CLB stock can currently be purchased for approximately $21.66.

Core Laboratories has a market capitalization of $963.00 million and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis. Core Laboratories employs 4,300 workers across the globe.

The official website for Core Laboratories is www.corelab.com.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]